Instituto Aragonés de Ciencias de la Salud-ko ikertzaileekin lankidetzan egindako argitalpenak (48)

2024

  1. APOE and familial hypercholesterolemia

    Current Opinion in Lipidology, Vol. 35, Núm. 4, pp. 195-199

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. Polyphenols and metabolism: from present knowledge to future challenges

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 3, pp. 603-625

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Contribution of APOE Genetic Variants to Dyslipidemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077

  3. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  4. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  5. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (The journal of nutrition, health & aging, (2017), 21, 1, (92-104), 10.1007/s12603-016-0803-1)

    Journal of Nutrition, Health and Aging

  6. MALDI-TOF MS as a tick identification tool in a tertiary hospital in Spain

    Acta Tropica, Vol. 242

2022

  1. Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts

    Frontiers in Medicine, Vol. 9

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. PBM: Now more than ever necessary

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 69, Núm. 6, pp. 351-354

2021

  1. Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 664-673

  2. Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers

    International Journal of Technology Assessment in Health Care, Vol. 37, Núm. 1

  3. Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making

    International Journal of Technology Assessment in Health Care, Vol. 37, Núm. 1

  4. Preoperative hemogram as a predictive factor for iron deficit and/or transfusion in patients scheduled for arthroplasty

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 68, Núm. 10, pp. 555-563

2020

  1. Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (Estahep clinical trial)

    Cancers, Vol. 12, Núm. 7, pp. 1-14

  2. Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness

    Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 846-856

  3. Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial

    Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25

  4. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1